Kang, Zhuang
Li, Shenglan
Lin, Yi
Li, Yongsheng
Mao, Ying
Zhang, Jing
Lei, Ting
Wang, Haidan
Su, Yangzhi
Yang, Yang
Qiu, Jingbo
Li, Wenbin
Funding for this research was provided by:
CSPC Pharmaceutical Group Limited
Article History
Received: 10 November 2022
Revised: 6 December 2022
Accepted: 7 December 2022
First Online: 8 March 2023
Statements and declarations
:
: HW, YS, YY, and JQ are employed by CSPC Pharmaceutical Group Limited. The other authors have no conflicts of interest.
: The studies involving human participants were reviewed and approved by an institutional review board at each participating site. This study is registered at chictr.org.cn (trial registration ID: ChiCTR2100045380).
: All patients provided written informed consent prior to the initiation of any study-related procedures.
: The authors affirm that human research participants provided informed consent for the publication of the images in Supplementary Figures S4 and S5.